Published in Law and Health Weekly, March 15th, 2008
"Across its business segments, DuPont is integrating biology with its expertise in chemistry to deliver its biotechnology pipeline to the marketplace. DuPont has stepped up its efforts, including today's leadership changes, to accelerate commercialization of its bio-based technologies to meet growing global demand," said DuPont Chairman and CEO Charles O. Holliday, Jr.
"Population growth, rising income and demand for bio-based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly